Drug Safety Information for SARAFEM (Fluoxetine hydrochloride)

Safety-related Labeling Changes for PROZAC (FLUOXETINE HYDROCHLORIDE) Rx Drug: FDA Link

Safety-related Labeling Changes for PROZAC WEEKLY (FLUOXETINE HYDROCHLORIDE) Discontinued Drug: FDA Link

Safety-related Labeling Changes for SYMBYAX (FLUOXETINE HYDROCHLORIDE; OLANZAPINE) Rx Drug: FDA Link

Safety-related Labeling Changes for SARAFEM (FLUOXETINE HYDROCHLORIDE) Rx Drug: FDA Link

Adverse Drug Reactions for SARAFEM* (Fluoxetine hydrochloride)

These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).

Top 20 Adverse Effects Associated with SARAFEM
(reported in FDA Medwatch/FAERS Reports)

  Side Effect # of FDA Reports
3Drug ineffective2649
13Completed suicide1695
15Drug interaction1581
17Suicidal ideation1483
18Weight increased*1479

* This side effect also appears in "Top 10 Side Effects of SARAFEM " in the drug's Review Summary based on AskaPatient reviews.

Top 10 Reasons for Taking SARAFEM
(associated with FDA Medwatch/FAERS Reports)

Reason # of FDA Reports
2Product used for unknown indication29346
4Obsessive-compulsive disorder*2195
5Major depression*1709
6Bipolar disorder*1437
7Antidepressant therapy905
8Affective disorder632
9Depressed mood586
10Ill-defined disorder574

*Also a top-10 reason in AskaPatient Review Summary.

Types of Adverse Events for SARAFEM

Total Reports Filed with FDA: 250602

Number of FDA Adverse Event Reports by Patient Age for SARAFEM

Total Reports Filed with FDA: 250602*

* Reports for drugs with the same active ingredients have been aggregated in this analysis: Fluoxetine hydrochloride (Selfemra, Fluoxetine, Fluox, Fluoxetina, Fluoxetine hcl, Prozac weekly, Sarafem, Prozac)

Charts are based on 250602 reports filed with the FDA between 2004 and June 2015.

Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.

Click to go back to search results and SARAFEM Reviews and Review Summary .

Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.

Visit   DrugInformer.com more on SARAFEM's side effects.